ID HCC60 AC CVCL_G002 SY HCC0060; Hamon Cancer Center 60 DR EFO; EFO_0006418 DR ArrayExpress; E-MTAB-2706 DR BioSample; SAMN03473068 DR cancercelllines; CVCL_G002 DR Cosmic; 1113279 DR EGA; EGAS00001000610 DR PharmacoDB; HCC60_507_2019 DR Wikidata; Q54881769 RX PubMed=12429618; RX PubMed=25485619; RX PubMed=25877200; RX PubMed=26589293; WW Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx CC Problematic cell line: Contaminated. Shown to be a NCI-H23 derivative (PubMed=25877200). Originally thought to originate from a 26 year old female patient with an ovarian cystadenocarcinoma. CC Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00533. CC Population: African American. CC HLA typing: A*80:01,80:01; B*50:01,50:01; C*06:02,06:02; DQB1*06:13,06:13; DRB1*13:01,03:17 (PubMed=26589293). CC Karyotypic information: Has lost chromosome Y (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gln1919Pro (c.5756A>C); ClinVar=VCV000580726; Zygosity=Homozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Trp332Ter (c.996G>A); ClinVar=VCV000376339; Zygosity=Homozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Ile (c.738G>C); ClinVar=VCV001758655; Zygosity=Homozygous (from parent cell line). CC Omics: Transcriptomics; RNAseq. CC Omics: Variations; SNP array analysis. CC Derived from site: In situ; Lung; UBERON=UBERON_0002048. ST Source(s): PubMed=25877200 ST Amelogenin: X ST CSF1PO: 10 ST D13S317: 12 ST D16S539: 11 ST D18S51: 14 ST D21S11: 30 ST D3S1358: 15 ST D5S818: 12,13 ST D7S820: 9,10 ST D8S1179: 15 ST FGA: 24 ST Penta D: 8 ST Penta E: 7,17 ST TH01: 6 ST TPOX: 8,9 ST vWA: 16,17 DI NCIt; C3512; Lung adenocarcinoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_1547 ! NCI-H23 SX Male AG 51Y CA Cancer cell line DT Created: 11-02-13; Last updated: 10-04-25; Version: 27 // RX PubMed=25877200; DOI=10.1038/nature14397; RA Yu, Ma-Mie RA Selvaraj, Suresh K. RA Liang-Chu, May M.Y. RA Aghajani, Sahar RA Busse, Matthew RA Yuan, Jean RA Lee, Genee RA Peale, Franklin V. RA Klijn, Christiaan RA Bourgon, Richard RA Kaminker, Joshua S. RA Neve, Richard M. RT "A resource for cell line authentication, annotation and quality RT control."; RL Nature 520:307-311(2015). // RX PubMed=26589293; DOI=10.1186/s13073-015-0240-5; PMCID=PMC4653878; RA Scholtalbers, Jelle RA Boegel, Sebastian RA Bukur, Thomas RA Byl, Marius RA Goerges, Sebastian RA Sorn, Patrick RA Loewer, Martin RA Sahin, Ugur RA Castle, John C. RT "TCLP: an online cancer cell line catalogue integrating HLA type, RT predicted neo-epitopes, virus and gene expression."; RL Genome Med. 7:118.1-118.7(2015). // RX PubMed=25485619; DOI=10.1038/nbt.3080; RA Klijn, Christiaan RA Durinck, Steffen RA Stawiski, Eric W. RA Haverty, Peter M. RA Jiang, Zhao-Shi RA Liu, Han-Bin RA Degenhardt, Jeremiah RA Mayba, Oleg RA Gnad, Florian RA Liu, Jin-Feng RA Pau, Gregoire RA Reeder, Jens RA Cao, Yi RA Mukhyala, Kiran RA Selvaraj, Suresh K. RA Yu, Ma-Mie RA Zynda, Gregory J. RA Brauer, Matthew J. RA Wu, Thomas D. RA Gentleman, Robert Clifford RA Manning, Gerard RA Yauch, Robert L. RA Bourgon, Richard RA Stokoe, David RA Modrusan, Zora RA Neve, Richard M. RA de Sauvage, Frederic J. RA Settleman, Jeffrey RA Seshagiri, Somasekar RA Zhang, Ze-Min RT "A comprehensive transcriptional portrait of human cancer cell RT lines."; RL Nat. Biotechnol. 33:306-312(2015). // RX PubMed=12429618; RA Rathi, Asha RA Virmani, Arvind K. RA Schorge, John O. RA Elias, Keren J. RA Maruyama, Riichiroh RA Minna, John D. RA Mok, Samuel C. RA Girard, Luc RA Fishman, David A. RA Gazdar, Adi F. RT "Methylation profiles of sporadic ovarian tumors and nonmalignant RT ovaries from high-risk women."; RL Clin. Cancer Res. 8:3324-3331(2002). //